Literature DB >> 2937349

Mitochondrial morphometrics of histochemically identified human extraocular muscle fibers.

M R Carry, S P Ringel, J M Starcevich.   

Abstract

Three fiber types--coarse, granular, and fine--were readily identified in histochemical cryostat sections of human extraocular muscle (EOM). The cryostat retrieval method was utilized to identify these three fiber types in serial electron microscopic thin sections. Using morphometric techniques, five mitochondrial variables (mitochondrial volume fraction, mitochondrial profile size, mitochondrial profile density, and clusters of two or of three or more mitochondrial profiles) were determined for a total of 162 histochemically identified fibers from two regions (orbital and global zones) from six EOMs. Coarse fibers had numerous large-sized mitochondrial profiles, often occurring in clusters. Granular fibers had fewer and smaller-sized profiles scattered across the fiber. Fine fibers had the most numerous, but smallest-sized mitochondrial profiles. Despite significant differences in group (fiber types) means for the mitochondrial variables, no single variable was sufficient for separating fiber types into distinct populations. Although a scattergram plot of two variables was sufficient to separate orbital zone fibers, a computer-generated, multivariate discriminant analysis was needed to separate the global zone fibers into distinct populations. These results will aid future studies on normal and pathological human EOM by providing a morphometric basis for identifying fiber types in the orbital and global zones.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2937349     DOI: 10.1002/ar.1092140103

Source DB:  PubMed          Journal:  Anat Rec        ISSN: 0003-276X


  8 in total

1.  Involvement of extraocular muscle in mitochondrial encephalomyopathy.

Authors:  S Takeda; E Ohama; F Ikuta
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

2.  Ragged-red fibres detected in paraffin sections by a monoclonal antibody to inner mitochondrial membrane.

Authors:  W Paulus; J Peiffer; W Roggendorf; K H Wiedmann; J M Schröder
Journal:  J Neurol       Date:  1989-12       Impact factor: 4.849

3.  Mitochondrial myopathies: divergences of genetic deletions, biochemical defects and the clinical syndromes.

Authors:  K D Gerbitz; B Obermaier-Kusser; S Zierz; D Pongratz; J Müller-Höcker; P Lestienne
Journal:  J Neurol       Date:  1990-02       Impact factor: 4.849

Review 4.  Muscle mitochondrial DNA in encephalomyopathy and ragged red fibres: a Southern blot analysis and literature review.

Authors:  C Geny; V Cormier; C Meyrignac; P Cesaro; J D Degos; R Gherardi; A Rötig
Journal:  J Neurol       Date:  1991-06       Impact factor: 4.849

Review 5.  Mouse models of oxidative phosphorylation defects: powerful tools to study the pathobiology of mitochondrial diseases.

Authors:  Alessandra Torraco; Francisca Diaz; Uma D Vempati; Carlos T Moraes
Journal:  Biochim Biophys Acta       Date:  2008-06-13

6.  Mitochondrial DNA defects and selective extraocular muscle involvement in CPEO.

Authors:  Laura C Greaves; Patrick Yu-Wai-Man; Emma L Blakely; Kim J Krishnan; Nina E Beadle; Jamie Kerin; Martin J Barron; Philip G Griffiths; Alison J Dickinson; Douglass M Turnbull; Robert W Taylor
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

7.  Somatic mitochondrial DNA deletions accumulate to high levels in aging human extraocular muscles.

Authors:  Patrick Yu-Wai-Man; Joey Lai-Cheong; Gillian M Borthwick; Langping He; Geoffrey A Taylor; Laura C Greaves; Robert W Taylor; Philip G Griffiths; Douglass M Turnbull
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-02-17       Impact factor: 4.799

8.  Extraocular Muscle Reveals Selective Vulnerability of Type IIB Fibers to Respiratory Chain Defects Induced by Mitochondrial DNA Alterations.

Authors:  Rafael R Oexner; David Pla-Martín; Thomas Paß; Martin H J Wiesen; Peter Zentis; Astrid Schauss; Olivier R Baris; Sammy Kimoloi; Rudolf J Wiesner
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-10-01       Impact factor: 4.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.